%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei
P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref007)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref009)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref010)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref011)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref012)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref013)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref014)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref015)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref016)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref017)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref018)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0172324.ref019)>>
endobj
13 0 obj
[26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R]
endobj
26 0 obj
<>stream
q
0.83 0.64 0.02 0 k
465.789 667.3323 m
470.5512 667.3323 l
h
f*
475.7102 667.3323 m
480.4724 667.3323 l
h
f*
339.5339 654.3496 m
349.0583 654.3496 l
h
f*
400.0252 654.3496 m
409.4929 654.3496 l
h
f*
512.6173 628.3276 m
522.1417 628.3276 l
h
f*
548.3906 602.3055 m
557.915 602.3055 l
h
f*
273.4866 563.3008 m
283.011 563.3008 l
h
f*
450.652 433.3039 m
460.1197 433.3039 l
h
f*
464.5984 433.3039 m
474.1228 433.3039 l
h
f*
344.2961 407.3386 m
353.8205 407.3386 l
h
f*
491.1874 203.1307 m
500.7118 203.1307 l
h
f*
526.0535 94.9039 m
535.578 94.9039 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 211.9748 707.4141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7858 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(cancer-related)Tj
5.9187 0 Td
(parameters)Tj
4.6715 0 Td
(available)Tj
3.668 0 Td
(to)Tj
1.0261 0 Td
(predict)Tj
3.0444 0 Td
(the)Tj
1.474 0 Td
(prognosis)Tj
4.1216 0 Td
(of)Tj
1.0148 0 Td
(breast)Tj
2.6135 0 Td
(cancer)Tj
-34.9679 -1.3039 Td
(patients)Tj
3.3675 0 Td
(has)Tj
1.542 0 Td
(grown)Tj
2.795 0 Td
(considerably)Tj
5.295 0 Td
(in)Tj
1.0318 0 Td
(recent)Tj
2.7099 0 Td
(years.)Tj
2.4889 0 Td
(Prognostic)Tj
4.5297 0 Td
(factors)Tj
2.9026 0 Td
(of)Tj
1.0148 0 Td
(breast)Tj
2.6136 0 Td
(cancer)Tj
2.8459 0 Td
(include)Tj
-33.1367 -1.2982 Td
(histological)Tj
4.7678 0 Td
(features)Tj
3.3505 0 Td
(\(histological)Tj
5.108 0 Td
(type,)Tj
2.1373 0 Td
(histological)Tj
4.7735 0 Td
(grade,)Tj
2.6646 0 Td
(lymphovascular)Tj
6.548 0 Td
(invasion\),)Tj
4.1725 0 Td
(tumor)Tj
-33.5222 -1.2983 Td
(size,)Tj
1.9105 0 Td
(lymph)Tj
2.7836 0 Td
(node)Tj
2.228 0 Td
(status,)Tj
2.7269 0 Td
(steroid)Tj
2.9764 0 Td
(hormone)Tj
3.9231 0 Td
(receptors)Tj
3.9174 0 Td
(status)Tj
2.5002 0 Td
(and)Tj
1.7291 0 Td
(age)Tj
1.5421 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.5965 0 Td
(Prognostic)Tj
4.524 0 Td
(and)Tj
1.7292 0 Td
(pre-)Tj
-35.087 -1.2983 Td
(dictive)Tj
2.8799 0 Td
(biomarkers,)Tj
5.006 0 Td
(including)Tj
4.0422 0 Td
(p53)Tj
1.6837 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(])Tj
1.8539 0 Td
(and)Tj
1.7291 0 Td
(Ki-67)Tj
2.4661 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(],)Tj
2.075 0 Td
(were)Tj
2.1203 0 Td
(also)Tj
1.7688 0 Td
(identified)Tj
4.0592 0 Td
(in)Tj
1.0374 0 Td
(breast)Tj
2.6136 0 Td
(cancer.)Tj
/F10 1 Tf
-33.3352 -1.3039 Td
[()]TJ
/F5 1 Tf
1.695 0 Td
(\(also)Tj
2.1033 0 Td
(known)Tj
2.9991 0 Td
(as)Tj
1.0091 0 Td
(TP53\))Tj
2.6759 0 Td
(locates)Tj
2.9083 0 Td
(on)Tj
1.2699 0 Td
(chromosome)Tj
5.4822 0 Td
(17p13)Tj
2.6362 0 Td
(and)Tj
1.7235 0 Td
(encodes)Tj
3.4299 0 Td
(p53)Tj
1.6837 0 Td
(transcription)Tj
5.4312 0 Td
(factor.)Tj
-35.0473 -1.2982 Td
(P53)Tj
1.7291 0 Td
(plays)Tj
2.2336 0 Td
(a)Tj
0.652 0 Td
(vital)Tj
1.9219 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0375 0 Td
(determining)Tj
5.176 0 Td
(cell)Tj
1.559 0 Td
(fate)Tj
1.6668 0 Td
(exposed)Tj
3.4469 0 Td
(to)Tj
1.0205 0 Td
(DNA)Tj
2.3811 0 Td
(damage)Tj
3.3222 0 Td
(stimuli)Tj
3.0047 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0806 0 Td
(Alterations)Tj
-33.0007 -1.2983 Td
(of)Tj
1.0148 0 Td
(p53)Tj
1.6894 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.1203 0 Td
(investigated)Tj
4.989 0 Td
(with)Tj
2.0012 0 Td
(particular)Tj
4.1102 0 Td
(interest)Tj
3.2088 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(recent)Tj
2.7099 0 Td
(years.)Tj
2.4888 0 Td
(Studies)Tj
3.1011 0 Td
(suggest)Tj
3.1238 0 Td
(that)Tj
/F10 1 Tf
-35.121 -1.3039 Td
[()]TJ
/F5 1 Tf
1.695 0 Td
(gene)Tj
2.0807 0 Td
(is)Tj
0.8503 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
2.2053 0 Td
(frequently)Tj
4.3087 0 Td
(mutated)Tj
3.5546 0 Td
(tumor)Tj
2.7439 0 Td
(suppressor)Tj
4.5354 0 Td
(gene)Tj
2.0806 0 Td
(in)Tj
1.0375 0 Td
(human)Tj
3.0784 0 Td
(malignancy)Tj
4.8586 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(],)Tj
-34.4974 -1.2983 Td
(and)Tj
1.7291 0 Td
(30%)Tj
1.9275 0 Td
(breast)Tj
2.6135 0 Td
(cancers)Tj
3.2088 0 Td
(have)Tj
/F10 1 Tf
2.058 0 Td
[()]TJ
/F5 1 Tf
1.7007 0 Td
(mutation.)Tj
4.1443 0 Td
(The)Tj
1.7858 0 Td
(frequency)Tj
4.1839 0 Td
(of)Tj
/F10 1 Tf
1.0148 0 Td
[()]TJ
/F5 1 Tf
1.7008 0 Td
(mutation)Tj
3.9174 0 Td
(in)Tj
1.0375 0 Td
(breast)Tj
2.6135 0 Td
(cancer)Tj
-33.6356 -1.2983 Td
(relies)Tj
2.313 0 Td
(on)Tj
1.2756 0 Td
(molecular)Tj
4.2179 0 Td
(subset,)Tj
2.9253 0 Td
(luminal)Tj
3.3052 0 Td
(subgroup)Tj
4.0082 0 Td
(has)Tj
1.542 0 Td
(lowest)Tj
2.7383 0 Td
(mutation)Tj
3.9231 0 Td
(and)Tj
1.7291 0 Td
(basal)Tj
2.1997 0 Td
(subgroup)Tj
4.0081 0 Td
(has)Tj
-34.1855 -1.3039 Td
(highest)Tj
3.0897 0 Td
(mutation)Tj
3.9174 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0807 0 Td
(The)Tj
1.7801 0 Td
(mutation)Tj
3.9231 0 Td
(of)Tj
/F10 1 Tf
1.0148 0 Td
[()]TJ
/F5 1 Tf
1.6951 0 Td
(gene)Tj
2.0863 0 Td
(may)Tj
1.9276 0 Td
(represents)Tj
4.3199 0 Td
(an)Tj
1.2019 0 Td
(early)Tj
2.1487 0 Td
(event)Tj
2.3697 0 Td
(in)Tj
1.0318 0 Td
(tumor)Tj
2.7439 0 Td
(prog-)Tj
-35.3307 -1.2982 Td
(ress,)Tj
1.9615 0 Td
(because)Tj
3.3165 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8504 0 Td
(evident)Tj
3.1635 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4683 0 Td
(in)Tj
1.0375 0 Td
(situ)Tj
1.6724 0 Td
(phase)Tj
2.4832 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8459 0 Td
(growth.)Tj
3.2996 0 Td
(Additionally,)Tj
/F10 1 Tf
5.4538 0 Td
[()]TJ
/F5 1 Tf
1.6951 0 Td
(mutation)Tj
-32.0029 -1.2983 Td
(probably)Tj
3.7643 0 Td
(stimulates)Tj
4.2576 0 Td
(cell)Tj
1.5591 0 Td
(proliferation)Tj
5.2667 0 Td
(and)Tj
1.7291 0 Td
(renders)Tj
3.2485 0 Td
(aggressive)Tj
4.2463 0 Td
(phenotype.)Tj
4.6601 0 Td
(The)Tj
1.7858 0 Td
(availability)Tj
4.5298 0 Td
(of)Tj
-35.0473 -1.3039 Td
(detecting)Tj
3.8947 0 Td
(mutant)Tj
3.1465 0 Td
(p53)Tj
1.6894 0 Td
(protein)Tj
3.1521 0 Td
(on)Tj
1.2756 0 Td
(formalin-fixed)Tj
6.0264 0 Td
(paraffin-embedded)Tj
7.8973 0 Td
(\(FFPE\))Tj
3.084 0 Td
(tissue)Tj
2.4605 0 Td
(has)Tj
1.542 0 Td
(allowed)Tj
-34.1685 -1.2983 Td
(the)Tj
1.4683 0 Td
(retrospective)Tj
5.3631 0 Td
(studies)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(long)Tj
1.9899 0 Td
(follow-up.)Tj
-17.6427 -1.2982 Td
(Ki-67)Tj
2.4661 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(non-histone)Tj
5.108 0 Td
(nuclear)Tj
3.1918 0 Td
(protein)Tj
3.1521 0 Td
(and)Tj
1.7348 0 Td
(correlated)Tj
4.2463 0 Td
(with)Tj
1.9956 0 Td
(cell)Tj
1.559 0 Td
(growth.)Tj
3.2995 0 Td
(Ki-67)Tj
2.4605 0 Td
(expression)Tj
-31.9122 -1.2983 Td
(varies)Tj
2.5284 0 Td
(through)Tj
3.4469 0 Td
(cell)Tj
1.5591 0 Td
(cycle,)Tj
2.4151 0 Td
(with)Tj
2.0012 0 Td
(different)Tj
3.6567 0 Td
(expression)Tj
4.4617 0 Td
(levels)Tj
2.3754 0 Td
(in)Tj
1.0375 0 Td
(G1,)Tj
1.6384 0 Td
(G2/M,)Tj
2.8573 0 Td
(and)Tj
1.7291 0 Td
(S)Tj
0.6974 0 Td
(phases)Tj
2.8403 0 Td
(but)Tj
1.5533 0 Td
(unde-)Tj
-34.7978 -1.3039 Td
(tectable)Tj
3.2711 0 Td
(in)Tj
1.0375 0 Td
(G0)Tj
1.4116 0 Td
(phase.)Tj
2.7099 0 Td
(Ki-67)Tj
2.4605 0 Td
(associates)Tj
4.0932 0 Td
(with)Tj
1.9956 0 Td
(cell)Tj
1.559 0 Td
(cycle)Tj
2.1883 0 Td
(progress)Tj
3.6 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(short)Tj
2.2904 0 Td
(half-life)Tj
3.2881 0 Td
(confer)Tj
2.7836 0 Td
(it)Tj
-35.8863 -1.2983 Td
(an)Tj
1.2018 0 Td
(effective)Tj
3.5093 0 Td
(biomarker)Tj
4.4163 0 Td
(for)Tj
1.389 0 Td
(assessing)Tj
3.7984 0 Td
(growth)Tj
3.0727 0 Td
(fraction)Tj
3.3619 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
2.7439 0 Td
(cells.)Tj
2.143 0 Td
(Ki-67)Tj
2.4661 0 Td
(is)Tj
0.8448 0 Td
(one)Tj
1.7007 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
-34.1459 -1.2983 Td
(widely)Tj
2.8232 0 Td
(used)Tj
2.058 0 Td
(immunohistochemistr)Tj
8.9461 0 Td
(y)Tj
0.6746 0 Td
(\(IHC\))Tj
2.6702 0 Td
(proliferation)Tj
5.2668 0 Td
(antigen)Tj
3.2031 0 Td
(and)Tj
1.7291 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(confirmed)Tj
4.3937 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
-36.4476 -1.3039 Td
(independent)Tj
5.2723 0 Td
(predictive)Tj
4.1953 0 Td
(and)Tj
1.7291 0 Td
(prognostic)Tj
4.4844 0 Td
(factor)Tj
2.5455 0 Td
(in)Tj
1.0375 0 Td
(breast)Tj
2.6135 0 Td
(cancer)Tj
2.846 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(16)Tj
0 g
(].)Tj
1.7347 0 Td
(Ki-67)Tj
2.4662 0 Td
(is)Tj
0.8447 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
-32.7059 -1.2982 Td
(parameter)Tj
4.3142 0 Td
(in)Tj
1.0318 0 Td
(sub-classifying)Tj
6.0832 0 Td
(luminal)Tj
3.3108 0 Td
(tumors)Tj
3.1068 0 Td
(into)Tj
1.8368 0 Td
(a)Tj
0.6576 0 Td
(good)Tj
2.2224 0 Td
(prognosis)Tj
4.1272 0 Td
(luminal)Tj
3.3108 0 Td
(A)Tj
0.9014 0 Td
(subtype)Tj
3.3109 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
-35.943 -1.2983 Td
(worse)Tj
2.5624 0 Td
(prognosis)Tj
4.1216 0 Td
(luminal)Tj
3.3052 0 Td
(B)Tj
0.7937 0 Td
(subtype)Tj
3.3051 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.075 0 Td
(While)Tj
2.6475 0 Td
(the)Tj
1.4684 0 Td
(prognostic)Tj
4.4787 0 Td
(value)Tj
2.3017 0 Td
(of)Tj
1.0148 0 Td
(Ki-67)Tj
2.4548 0 Td
(in)Tj
1.0318 0 Td
(TNBC)Tj
2.8063 0 Td
(remains)Tj
-34.367 -1.3039 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1507 0 Td
(determined.)Tj
-0.9807 -1.2983 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(current)Tj
3.1861 0 Td
(study,)Tj
2.6135 0 Td
(we)Tj
1.3266 0 Td
(investigated)Tj
4.989 0 Td
(the)Tj
1.474 0 Td
(association)Tj
4.6261 0 Td
(between)Tj
3.5263 0 Td
(p53,)Tj
1.9162 0 Td
(Ki-67,)Tj
2.6872 0 Td
(clinical)Tj
3.0784 0 Td
(character-)Tj
-33.1991 -1.2983 Td
(istics,)Tj
2.4207 0 Td
(family)Tj
2.7326 0 Td
(history)Tj
3.0047 0 Td
(of)Tj
1.0148 0 Td
(cancer,)Tj
3.0727 0 Td
(and)Tj
1.7292 0 Td
(recurrence,)Tj
4.7508 0 Td
(DFS)Tj
1.9616 0 Td
(and)Tj
1.7291 0 Td
(OS)Tj
1.4456 0 Td
(in)Tj
1.0318 0 Td
(TNBC)Tj
2.812 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 343.2188 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Patients)Tj
3.7937 0 Td
(and)Tj
1.8661 0 Td
(methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 308.1826 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(One)Tj
1.9388 0 Td
(hundred)Tj
3.6737 0 Td
(and)Tj
1.7291 0 Td
(fifty-six)Tj
3.2599 0 Td
(TNBC)Tj
2.8119 0 Td
(patients)Tj
3.3675 0 Td
(treated)Tj
2.9991 0 Td
(at)Tj
0.9524 0 Td
(Anyang)Tj
3.3505 0 Td
(Tumor)Tj
3.0614 0 Td
(Hospital)Tj
3.617 0 Td
(from)Tj
2.2054 0 Td
(August)Tj
-32.9667 -1.2982 Td
(2010)Tj
2.1203 0 Td
(to)Tj
1.0261 0 Td
(December)Tj
4.3483 0 Td
(2013)Tj
2.1203 0 Td
(were)Tj
2.126 0 Td
(included)Tj
3.7133 0 Td
(in)Tj
1.0318 0 Td
(this)Tj
1.6781 0 Td
(study.)Tj
2.6136 0 Td
(All)Tj
1.3946 0 Td
(of)Tj
1.0148 0 Td
(medical)Tj
3.3619 0 Td
(records)Tj
3.2031 0 Td
(were)Tj
2.126 0 Td
(reviewed)Tj
3.7927 0 Td
(ret-)Tj
-35.6709 -1.2983 Td
(rospectively.)Tj
5.193 0 Td
(The)Tj
1.7801 0 Td
(inclusion)Tj
3.9175 0 Td
(criteria)Tj
3.0784 0 Td
(for)Tj
1.3833 0 Td
(all)Tj
1.1452 0 Td
(participants)Tj
4.9606 0 Td
(were:)Tj
2.3471 0 Td
(aged)Tj
2.0692 0 Td
(18)Tj
1.1736 0 Td
(years;)Tj
2.4888 0 Td
(diagnosis)Tj
3.9571 0 Td
(of)Tj
1.0148 0 Td
(TNBC.)Tj
-34.5087 -1.3039 Td
(Exclusion)Tj
4.1328 0 Td
(criteria)Tj
3.0784 0 Td
(were:)Tj
2.3471 0 Td
(preoperative)Tj
5.2271 0 Td
(chemotherapy)Tj
5.9527 0 Td
(or)Tj
1.0942 0 Td
(radiotherapy;)Tj
5.5785 0 Td
(deficiency)Tj
4.269 0 Td
(of)Tj
1.0147 0 Td
(clinical)Tj
3.0785 0 Td
(data)Tj
-35.773 -1.2983 Td
(or)Tj
1.0941 0 Td
(lack)Tj
1.8255 0 Td
(of)Tj
1.0148 0 Td
(follow)Tj
2.6986 0 Td
(up.)Tj
1.4853 0 Td
(All)Tj
1.4003 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1203 0 Td
(diagnosed)Tj
4.2803 0 Td
(TNBC)Tj
2.8119 0 Td
(because)Tj
3.3222 0 Td
(both)Tj
2.0579 0 Td
(estrogen)Tj
3.617 0 Td
(and)Tj
1.7348 0 Td
(progester-)Tj
-32.8306 -1.2982 Td
(one)Tj
1.6951 0 Td
(receptor)Tj
3.5602 0 Td
(were)Tj
2.1204 0 Td
(0%)Tj
1.4513 0 Td
(by)Tj
1.1849 0 Td
(IHC,)Tj
2.2166 0 Td
(and)Tj
1.7292 0 Td
(HER2)Tj
2.6532 0 Td
(was)Tj
1.7007 0 Td
(0%)Tj
1.4514 0 Td
(by)Tj
1.1792 0 Td
(IHC)Tj
1.9956 0 Td
(or)Tj
1.0941 0 Td
(1+)Tj
1.2756 0 Td
(and)Tj
1.7348 0 Td
(2+)Tj
1.2699 0 Td
(score)Tj
2.3074 0 Td
(without)Tj
3.3335 0 Td
(gene)Tj
-33.9531 -1.3039 Td
(amplification)Tj
5.5388 0 Td
(confirmed)Tj
4.3937 0 Td
(by)Tj
1.1792 0 Td
(FISH.)Tj
2.5568 0 Td
(FFPE)Tj
2.4038 0 Td
(tumor)Tj
2.7439 0 Td
(samples)Tj
3.3846 0 Td
(were)Tj
2.1203 0 Td
(selected)Tj
3.3505 0 Td
(for)Tj
1.3833 0 Td
(IHC)Tj
1.9956 0 Td
(staining)Tj
3.4072 0 Td
(with)Tj
-34.4577 -1.2983 Td
(primary)Tj
3.4525 0 Td
(antibody)Tj
3.7644 0 Td
(against)Tj
3.0274 0 Td
(p53)Tj
1.6894 0 Td
(and)Tj
1.7292 0 Td
(Ki-67.)Tj
2.6929 0 Td
(Tissue)Tj
2.7665 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(p53)Tj
1.6895 0 Td
(positive)Tj
3.3165 0 Td
(if)Tj
0.7767 0 Td
(any)Tj
1.6554 0 Td
(cancer)Tj
2.846 0 Td
(cells)Tj
-35.3478 -1.2983 Td
(positively)Tj
4.0138 0 Td
(stained.)Tj
3.3052 0 Td
(We)Tj
1.61 0 Td
(considered)Tj
4.6035 0 Td
(a)Tj
0.6519 0 Td
(high)Tj
2.0069 0 Td
(Ki-67)Tj
2.4662 0 Td
(index)Tj
/F11 1 Tf
0 Tc
2.4491 0 Td
()Tj
/F5 1 Tf
-0.004 Tc
(14%)Tj
2.6986 0 Td
(cell)Tj
1.559 0 Td
(staining)Tj
3.4129 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0749 0 Td
(This)Tj
1.9899 0 Td
(study)Tj
2.3868 0 Td
(was)Tj
-35.2287 -1.2982 Td
(approved)Tj
3.9741 0 Td
(by)Tj
1.1792 0 Td
(Anyang)Tj
3.3562 0 Td
(Tumor)Tj
3.0557 0 Td
(Hospital)Tj
3.617 0 Td
(Ethics)Tj
2.6702 0 Td
(and)Tj
1.7292 0 Td
(Scientific)Tj
3.9004 0 Td
(Committee.)Tj
4.9663 0 Td
(Inquiries)Tj
3.8324 0 Td
(about)Tj
2.4945 0 Td
(the)Tj
-34.7752 -1.304 Td
(date)Tj
1.9048 0 Td
(and)Tj
1.7291 0 Td
(mode)Tj
2.4945 0 Td
(of)Tj
1.0148 0 Td
(death)Tj
2.4321 0 Td
(were)Tj
2.126 0 Td
(made)Tj
2.4208 0 Td
(by)Tj
1.1848 0 Td
(directly)Tj
3.2315 0 Td
(corresponding)Tj
6.0605 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(referring)Tj
3.753 0 Td
(physician)Tj
-31.8158 -1.2982 Td
(and/or)Tj
2.9366 0 Td
(the)Tj
1.4684 0 Td
(family)Tj
2.7325 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(deceased)Tj
3.7644 0 Td
(patient,)Tj
3.2314 0 Td
(with)Tj
1.9956 0 Td
(written)Tj
3.1124 0 Td
(permission)Tj
4.6658 0 Td
(obtained)Tj
3.7304 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.474 0 Td
(time)Tj
2.024 0 Td
(of)Tj
-34.5711 -1.2983 Td
(undertaking)Tj
5.125 0 Td
(surgery)Tj
3.1974 0 Td
(from)Tj
2.2054 0 Td
(all)Tj
1.1451 0 Td
(patients)Tj
3.3676 0 Td
(and/or)Tj
2.9423 0 Td
(their)Tj
2.1033 0 Td
(relatives,)Tj
3.7304 0 Td
(allowing)Tj
3.617 0 Td
(the)Tj
1.4683 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(personal)Tj
3.6283 0 Td
(data)Tj
-35.0756 -1.3039 Td
(for)Tj
1.3832 0 Td
(research)Tj
3.5547 0 Td
(purposes.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 112.9889 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Follow-up)Tj
4.4976 0 Td
(and)Tj
1.8662 0 Td
(statistical)Tj
4.2803 0 Td
(snalysis)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 95.9811 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Breast)Tj
2.6872 0 Td
(cancer)Tj
2.8459 0 Td
(recurrence)Tj
4.5241 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(regional)Tj
3.4866 0 Td
(or)Tj
1.0942 0 Td
(distant)Tj
2.9593 0 Td
(relapse)Tj
2.9934 0 Td
(in)Tj
1.0375 0 Td
(any)Tj
1.6554 0 Td
(site)Tj
1.5704 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0749 0 Td
(Dis-)Tj
-34.3386 -1.2982 Td
(ease-free)Tj
3.719 0 Td
(survival)Tj
3.3335 0 Td
(\(DFS\))Tj
2.6419 0 Td
(was)Tj
1.7008 0 Td
(calculated)Tj
4.2009 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(time)Tj
2.0239 0 Td
(from)Tj
2.2053 0 Td
(initial)Tj
2.5512 0 Td
(diagnosis)Tj
3.9571 0 Td
(to)Tj
1.0262 0 Td
(recurrence,)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 495.8929 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(P53)Tj
1.97 0 Td
(and)Tj
1.8568 0 Td
(Ki-67)Tj
2.5157 0 Td
(in)Tj
0.978 0 Td
(TNBC)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0172)Tj
3.5434 0 Td
(324)Tj
2.6362 0 Td
(February)Tj
4.1599 0 Td
(24,)Tj
1.5874 0 Td
(2017)Tj
37.3538 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
BT
66.402 0 Td
(13)Tj
ET
Q
endstream
endobj
42 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 46 0 R/Contents 47 0 R/TrimBox[0 0 612 792]>>
endobj
45 0 obj
<>stream
JFIF C
$, !$4.763.22:ASF:=N>22HbINVX]^]8EfmeZlS[]Y C**Y;2;YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY C
o"
} !1AQa"q2#BR$3br
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz
w !1AQaq"2B #3Rbr
$4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ? (
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
}"Gbu9Sw pF^_?2( ( (_k:no/7ր/Y6$n jx
d kW -yě|LV+c_%xW WWN J]سNI
6IX[u,p *м/VwL@4TpOBX%IcnT QQMq-7Kɺ)E`E >*9f4v f$_CY'dmʜ<3a9 뱁\ UϩI&